3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| EP4 receptor antagonist 1 | 2287259-07-6 | |
| Avatrombopag | 阿伐曲泊帕 | 570406-98-3 |
| D75-4590 | 化合物 D75-4590 | 384376-42-5 |
| Mocravimod hydrochloride | 2-氨基-2-[2-[2-氯-4-[[3-(苄氧基)苯基]硫]苯基]乙基]-1,3-丙二醇盐酸盐 | 509088-69-1 |
| Resiquimod-d5 | Resiquimod D5 | 2252319-44-9 |
| SR-31747 | SR 31747 | 132173-07-0 |
| Penehyclidine hydrochloride | 盐酸戊乙奎醚 | 151937-76-7 |
| Lysophosphatidylcholines | L-溶血卵磷脂 | 9008-30-4 |
| BIO-1211 | 化合物BIO-1211 | 187735-94-0 |
| MSA-2 dimer | 2377881-92-8 | |
| Levocabastine hydrochloride | 1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride | 79547-78-7 |
| GSK2647544 | 化合物 GSK2647544 | 1380426-95-8 |
| XT2 | 化合物 XT2 | 2582816-37-1 |
| Sorbicillin | (2E,4E)-1-(2,4-二羟基-3,5-二甲基苯基)己-2,4-二烯-1-酮 | 79950-85-9 |
| GSK2556286 | 化合物GSK2556286 | 1210456-20-4 |
| Evatanepag | 2-[3-[N-(4-叔丁基苄基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸 | 223488-57-1 |
| Camobucol | 216167-92-9 | 216167-92-9 |
| CZC24832 | 5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺 | 1159824-67-5 |
| Timapiprant sodium | 950688-14-9 | |
| Funapide | 1259933-16-8 | |
| Gemilukast | 1232861-58-3 | 1232861-58-3 |
| SGK1-IN-1 | N-[4-(3-amino-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]-5-chloro-2-fluorobenzenesulfonamide | 1279829-87-6 |
| TLR7/8-IN-1 | 2205095-75-4 | |
| (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine | N1-(苯并呋喃-2-基(吡啶-3-基)甲基)-N4-((S)-1-((2S,4R)-4-羟基-2-(((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)丁二酰胺 | 2347517-69-3 |
| AP-1/NF-κB activation inhibitor 1 | AP-1/NF-ΚB活性抑制剂1 | 188936-12-1 |
| Integrin modulator 1 | 2023788-32-9 | |
| VAF347 | 2-PYRIMIDINAMINE, 4-(3-CHLOROPHENYL)-N-[4-(TRIFLUOROMETHYL)PHENYL]- | 574759-62-9 |
| PHD-1-IN-1 | 化合物PHD-1-IN-1 | 2009343-14-8 |
| AGN194204 | 220619-73-8 | 220619-73-8 |
| Zaloglanstat | 1513852-12-4 | |
| TAPI-1 | 163847-77-6 | 163847-77-6 |
| Pumaprazole | 158364-59-1 | 158364-59-1 |
| SMS1-IN-1 | 1807943-38-9 | |
| AXC-715 trihydrochloride | 1-(4-Aminobutyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine Trihydrochloride | 2479276-17-8 |
| ALOX15-IN-2 | 化合物 ALOX15-IN-2 | 2764818-23-5 |
| WAY-204688 | 796854-35-8 | 796854-35-8 |
| GNE-6468 | 化合物 T15404 | 1677668-27-7 |
| Lexacalcitol | 来沙骨化醇 | 131875-08-6 |
| Eldecalcitol | 艾地骨化醇 | 104121-92-8 |
| Carvedilol-d4 | (±)-Carvedilol-d4 | 1133705-56-2 |
| Amodiaquine dihydrochloride | 盐酸阿莫地喹 | 69-44-3 |
| Taurocholic acid-d4 (sodium) | 牛磺胆酸钠盐 | 2410279-93-3 |
| Aspirin Aluminum | 乙酰水杨酸铝 | 23413-80-1 |
| Cloperastine fendizoate | 氯苄哌醚联苯酰苯酸盐 | 85187-37-7 |
| Tiron | 邻苯二酚-3,5-二磺酸钠 | 149-45-1 |
| Fenoprofen | 3 - (4 -苯氧基苯基)丙酸 | 29679-58-1 |
| FK706 | 144055-55-0 | |
| Menbutone | 孟布酮 | 3562-99-0 |
| Glafenine hydrochloride | 格拉非宁 盐酸盐 | 65513-72-6 |
| Triprolidine hydrochloride monohydrate | 盐酸曲普利啶 | 6138-79-0 |
| CXCR2-IN-2 | 1838123-21-9 | |
| CXCR2 antagonist 2 | 化合物 CXCR2 ANTAGONIST 2 | 2647464-91-1 |
| ACT-1004-1239 | 2178049-58-4 | |
| ACT-660602 | 化合物 ACT-660602 | 1646267-59-5 |
| AZD-5069 | AZD5069 | 878385-84-3 |
| NBI-74330 | N-[(1R)-1-[3-(4-乙氧基苯基)-3,4-二氢-4-氧代吡啶并[2,3-D]嘧啶-2-基]乙基]-4-氟-N-(3-吡啶基甲基)-3-(三氟甲基)苯乙酰胺 | 855527-92-3 |
| (R,R)-CXCR2-IN-2 | 1838123-22-0 | |
| TAK-779 | TAK 799 ;TAK 779 | 229005-80-5 |
| Kynurenic acid sodium | Kynurenic acid sodium salt | 2439-02-3 |
| AMD-070 | N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺 | 558447-26-0 |
| Reparixin | REPERTAXIN | 266359-83-5 |
| AMD-070 trihydrochloride | N-(1H-苯并咪唑-2-基甲基)-N-[(8S)-5,6,7,8-四氢-8-喹啉基]-1,4-丁二胺单盐酸盐 | 880549-30-4 |
| (2,5-Dioxopyrrolidin-1-yl) 6-[2-[(E,3Z)-3-(3-ethyl-1,3-benzoxazol-2-ylidene)prop-1-enyl]-1,3-benzoxazol-3-ium-3-yl]hexanoate;iodide | Cy2-NHS活化酯 | 186205-33-4 |
| Cyanine 3.5 carboxylic acid | Cy3.5羧酸 | 1144107-79-8 |
| Cy3 amine | Cy3-伯胺 | 2247688-56-6 |
| Cyanine3 maleimide | Cy3-马来酰亚胺 | 1593644-29-1 |
| Cecropin A | 抗菌肽A | 80451-04-3 |
| IDR-1 | 940291-10-1 | |
| SMAP-29 | SMAP 29 | 172485-26-6 |
| Sabatolimab | 2252262-24-9 | |
| Vedolizumab | 维多珠单抗 | 943609-66-3 |
| Tocilizumab | 托珠单抗 | 375823-41-9 |
| Cy5-NHS ester | Cy5-NHS 活化酯 | 1032678-42-4 |
| Cyanine 5 amine | Cy5-伯胺 | 1807529-70-9 |
| Caplacizumab | 卡拉西单抗 | 915810-67-2 |
| Dupilumab | 度匹鲁单抗 | 1190264-60-8 |
| Tiopinac | 硫平酸 | 61220-69-7 |
| Deprodone propionate | 丙酸地泼罗酮 | 20424-00-4 |
| 3-Acetamidocoumarin | 3-乙酰氨基香豆素 | 779-30-6 |
| Dimethyl sulfoxide | 二甲基亚砜 | 67-68-5 |
| Vudalimab | 2329669-72-7 | |
| Abatacept | Unii-7D0yb67S97 | 332348-12-6 |
| Ipilimumab | 伊匹单抗 | 477202-00-9 |
| CXCR7 modulator 1 | 2231812-31-8 | |
| Fresolimumab | 非苏木单抗 | 948564-73-6 |
| Parcetasal | MR 897 | 87549-36-8 |
| PPA-904 | 30189-85-6 | |
| SM-276001 | 473930-22-2 | |
| NUCC-390 dihydrochloride | 化合物 NUCC-390 DIHYDROCHLORIDE | 2749281-71-6 |
| CXCR7 antagonist-1 | CXCR7拮抗剂1 | 1613021-99-0 |
| CXCR2 antagonist 8 | 化合物 CXCR2 ANTAGONIST 8 | 182498-30-2 |
| SCH 527123 | 3-[[3-[(二甲基氨基)羰基]-2-羟基苯基]氨基]-4-[[(R)-1-(5-甲基呋喃-2-基)丙基]氨基]-3-环丁烯-1,2-二酮 | 473727-83-2 |
| Cyanine3.5 NHS ester | Cy3.5-NHS 活化酯 | 2231670-85-0 |
| Adalimumab | 阿达木单抗 | 331731-18-1 |
| Cyanine5 carboxylic acid | Cy5 羧酸 | 1032678-07-1 |
| Benralizumab | 1044511-01-4 | |
| K6PC-5 | 756875-51-1 | |
| MSX-127 | NSC-23026 | 6616-56-4 |
| TGN-020 | 51987-99-6 | |
| USL311 | 1373268-67-7 |
联系方式
